Growth hormone (GH) secretion in hepatic encephalopathy

Area of Science:

• Endocrinology
• Hepatology
• Neuroscience

Background:

• Cirrhosis is associated with altered growth hormone (GH) secretion patterns.
• Gut-derived false neurotransmitters are implicated in hepatic encephalopathy.
• Dopaminergic pathways may be affected in cirrhotic patients.

Purpose of the Study:

• To investigate basal GH levels and GH response to TRH and L-DOPA in cirrhotic patients.
• To compare these responses between cirrhotic patients with and without encephalopathy.
• To explore the relationship between GH secretion and neurotransmitter metabolism.

Main Methods:

• Measured basal GH plasma levels and GH response to TRH and L-DOPA.
• Studied 39 cirrhotic patients (11 with encephalopathy, 28 without) and 15 controls.
• Utilized statistical analysis to compare patient groups and controls.

Main Results:

• Cirrhotic patients exhibited significantly higher basal GH levels and TRH-induced GH response compared to controls.
• GH response to L-DOPA was significantly lower in encephalopathic patients.
• No significant difference in GH response to TRH was observed between encephalopathic and non-encephalopathic cirrhotic groups.

Conclusions:

• Elevated GH secretion and altered TRH response are present in cirrhosis.
• Reduced L-DOPA response in encephalopathic patients suggests central dopaminergic depletion.
• The role of TRH response in relation to monoamine metabolism abnormalities requires further investigation.